AENT vs. DRUG

Last updated Jun 24, 2026

AENT (Alliance Entertainment Holding Corporation Class A Common Stock) and DRUG (Bright Minds Biosciences Inc) are both stocks. AENT operates in Entertainment (Communication Services), while DRUG operates in Biotechnology (Healthcare). Over the past 5 years, AENT returned -9.51%/yr vs 22.77%/yr for DRUG. At a 0.04 correlation, their price movements are largely independent.

Performance

AENT vs. DRUG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alliance Entertainment Holding Corporation Class A Common Stock (AENT) and Bright Minds Biosciences Inc (DRUG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, AENT achieves a -27.48% return, which is significantly lower than DRUG's -16.54% return.

AENT

• 1D: 3.35%
• 1M: -4.87%
• YTD: -27.48%
• 6M: -25.35%
• 1Y: 91.50%
• 3Y*: 12.64%
• 5Y*: -9.51%
• 10Y*: —

DRUG

• 1D: 2.58%
• 1M: -22.00%
• YTD: -16.54%
• 6M: -22.71%
• 1Y: 140.42%
• 3Y*: 180.55%
• 5Y*: 22.77%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

AENT vs. DRUG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
AENT Alliance Entertainment Holding Corporation Class A Common Stock	-27.48%	-10.82%	876.08%	-90.88%	3.98%	-9.35%
DRUG Bright Minds Biosciences Inc	-16.54%	116.66%	2,418.88%	-61.35%	-76.66%	-40.76%

Correlation

The correlation between AENT and DRUG is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.11
Correlation (3Y) Calculated over the trailing 3-year period	0.04
Correlation (5Y) Calculated over the trailing 5-year period	0.04
Correlation (All Time) Calculated using the full available price history since Mar 24, 2021	0.04

Fundamentals

Market Cap AENT : $297.91B DRUG : $624.59M
EPS AENT : $0.00 DRUG : -CA$3.48
PB Ratio AENT : 2.48K DRUG : 2.88
Total Revenue (TTM) AENT : $1.11B DRUG : CA$0.00
Gross Profit (TTM) AENT : $150.69M DRUG : -CA$20.13K
EBITDA (TTM) AENT : $46.47M DRUG : -CA$31.36M

Return for Risk

AENT vs. DRUG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AENT

AENT Risk / Return Rank: 76
AENT Sharpe Ratio Rank: 76
AENT Sortino Ratio Rank: 77
AENT Omega Ratio Rank: 73
AENT Calmar Ratio Rank: 77
AENT Martin Ratio Rank: 77

DRUG

DRUG Risk / Return Rank: 86
DRUG Sharpe Ratio Rank: 88
DRUG Sortino Ratio Rank: 86
DRUG Omega Ratio Rank: 81
DRUG Calmar Ratio Rank: 87
DRUG Martin Ratio Rank: 87

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AENT vs. DRUG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Alliance Entertainment Holding Corporation Class A Common Stock (AENT) and Bright Minds Biosciences Inc (DRUG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	AENT	DRUG	Difference
Sharpe ratio: Return per unit of total volatility	1.15	1.93	-0.78
Sortino ratio: Return per unit of downside risk	2.00	2.67	-0.68
Omega ratio: Gain probability vs. loss probability	1.24	1.30	-0.06
Calmar ratio: Return relative to maximum drawdown	2.04	3.68	-1.65
Martin ratio: Return relative to average drawdown	5.16	9.54	-4.38

AENT vs. DRUG - Sharpe Ratio Comparison

The current AENT Sharpe Ratio is 1.15, which is lower than the DRUG Sharpe Ratio of 1.93. The chart below compares the historical Sharpe Ratios of AENT and DRUG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

AENT vs. DRUG - Drawdown Comparison

The maximum AENT drawdown since its inception was -93.11%, roughly equal to the maximum DRUG drawdown of -97.68%. Use the drawdown chart below to compare losses from any high point for AENT and DRUG.

Drawdown Indicators

	AENT	DRUG	Difference
Max Drawdown Largest peak-to-trough decline	-93.11%	-97.68%	+4.57%
Max Drawdown (1Y) Largest decline over 1 year	-45.20%	-38.35%	-6.85%
Max Drawdown (3Y) Largest decline over 3 years	-81.85%	-76.98%	-4.87%
Max Drawdown (5Y) Largest decline over 5 years	-92.91%	-97.68%	+4.77%
Current Drawdown Current decline from peak	-45.74%	-32.15%	-13.59%
Average Drawdown Average peak-to-trough decline	-43.88%	-58.73%	+14.85%
Ulcer Index Depth and duration of drawdowns from previous peaks	17.79%	14.78%	+3.01%

Volatility

AENT vs. DRUG - Volatility Comparison

The current volatility for Alliance Entertainment Holding Corporation Class A Common Stock (AENT) is 16.12%, while Bright Minds Biosciences Inc (DRUG) has a volatility of 18.91%. This indicates that AENT experiences smaller price fluctuations and is considered to be less risky than DRUG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	AENT	DRUG	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.12%	18.91%	-2.79%
Volatility (6M) Calculated over the trailing 6-month period	49.10%	43.32%	+5.78%
Volatility (1Y) Calculated over the trailing 1-year period	80.17%	73.38%	+6.79%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	91.32%	662.99%	-571.67%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	89.18%	646.38%	-557.20%

Dividends

AENT vs. DRUG - Dividend Comparison

Neither AENT nor DRUG has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both AENT and DRUG in my portfolio?

AENT and DRUG have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, AENT or DRUG?

DRUG has higher volatility (18.91%) compared to AENT (16.12%). In terms of maximum drawdown, AENT dropped -93.11% vs DRUG's -97.68%.

Which has better risk-adjusted returns?

DRUG currently has the higher Sharpe Ratio (1.93 vs 1.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.